异基因造血干细胞移植后出血性膀胱炎的相关危险因素。

IF 1.5 Q3 HEMATOLOGY 血液科学(英文) Pub Date : 2022-05-17 eCollection Date: 2022-04-01 DOI:10.1097/BS9.0000000000000110
Biao Shen, Yueshen Ma, Haixiao Zhang, Mingyang Wang, Jia Liu, Jiaxin Cao, Wenwen Guo, Dan Feng, Donglin Yang, Rongli Zhang, Xin Chen, Qiaoling Ma, Weihua Zhai, Sizhou Feng, Mingzhe Han, Aiming Pang, Erlie Jiang
{"title":"异基因造血干细胞移植后出血性膀胱炎的相关危险因素。","authors":"Biao Shen,&nbsp;Yueshen Ma,&nbsp;Haixiao Zhang,&nbsp;Mingyang Wang,&nbsp;Jia Liu,&nbsp;Jiaxin Cao,&nbsp;Wenwen Guo,&nbsp;Dan Feng,&nbsp;Donglin Yang,&nbsp;Rongli Zhang,&nbsp;Xin Chen,&nbsp;Qiaoling Ma,&nbsp;Weihua Zhai,&nbsp;Sizhou Feng,&nbsp;Mingzhe Han,&nbsp;Aiming Pang,&nbsp;Erlie Jiang","doi":"10.1097/BS9.0000000000000110","DOIUrl":null,"url":null,"abstract":"<p><p>Hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT). The incidence is about 7% to 68%, and some patients have to suffer a long period of frequent, urgent, and painful urination, which brings great pain. This study aimed to analyze risk factors of HC and its effect on patient survival. We collected the medical records of 859 patients who underwent HSCT at our hospital between August 2016 and August 2020. Patients with and without HC were matched using propensity score matching at a 1:1 ratio based on sex, age, and diagnosis, and logistic regression analyses were used to identify factors associated with HC. We used Kaplan-Meier curves to analyze the survival rates of patients in the HC and non-HC groups. We also analyzed the relationship between BK viral load and the occurrence of HC using receiver operating characteristic curve (ROC) analysis. After propensity score matching, there were 131 patients each in the HC and non-HC groups. In the HC group, 89 patients (67.9%) had mild HC (stage II°) and 43 (32.1%) had severe HC (stage III-IV). The median interval between stem cell transplantation and HC development was 31 (3-244) days. Univariate analysis indicated that donor age, hematopoietic stem cell source, HLA, acute graft-versus-host disease, busulfan, anti-thymocyte globulin (ATG), total body irradiation, cytomegalovirus (CMV) (urine), and BK polyomavirus (BKV) (urine) were significantly associated with HC. ATG, CMV (urine), and BKV (urine) were independent risk factors for HC based on the multivariate analysis. The Kaplan-Meier survival analysis showed no significant difference between the HC and non-HC groups (<i>P</i> = .14). The 1- and 2-year survival rates in the HC group were 78.4% and 69.6%, respectively, and the corresponding rates in the non-HC group were 84.4% and 80.7%, respectively. ROC analysis indicated that a urine BKV load of 1 × 10<sup>7</sup> copies/mL was able to stratify the risk of HC. In conclusion, when the BKV load is >1 × 10<sup>7</sup>, we need to be aware of the potential for the development of HC.</p>","PeriodicalId":67343,"journal":{"name":"血液科学(英文)","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2022-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/7e/bls-4-83.PMC9362868.pdf","citationCount":"3","resultStr":"{\"title\":\"Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.\",\"authors\":\"Biao Shen,&nbsp;Yueshen Ma,&nbsp;Haixiao Zhang,&nbsp;Mingyang Wang,&nbsp;Jia Liu,&nbsp;Jiaxin Cao,&nbsp;Wenwen Guo,&nbsp;Dan Feng,&nbsp;Donglin Yang,&nbsp;Rongli Zhang,&nbsp;Xin Chen,&nbsp;Qiaoling Ma,&nbsp;Weihua Zhai,&nbsp;Sizhou Feng,&nbsp;Mingzhe Han,&nbsp;Aiming Pang,&nbsp;Erlie Jiang\",\"doi\":\"10.1097/BS9.0000000000000110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT). The incidence is about 7% to 68%, and some patients have to suffer a long period of frequent, urgent, and painful urination, which brings great pain. This study aimed to analyze risk factors of HC and its effect on patient survival. We collected the medical records of 859 patients who underwent HSCT at our hospital between August 2016 and August 2020. Patients with and without HC were matched using propensity score matching at a 1:1 ratio based on sex, age, and diagnosis, and logistic regression analyses were used to identify factors associated with HC. We used Kaplan-Meier curves to analyze the survival rates of patients in the HC and non-HC groups. We also analyzed the relationship between BK viral load and the occurrence of HC using receiver operating characteristic curve (ROC) analysis. After propensity score matching, there were 131 patients each in the HC and non-HC groups. In the HC group, 89 patients (67.9%) had mild HC (stage II°) and 43 (32.1%) had severe HC (stage III-IV). The median interval between stem cell transplantation and HC development was 31 (3-244) days. Univariate analysis indicated that donor age, hematopoietic stem cell source, HLA, acute graft-versus-host disease, busulfan, anti-thymocyte globulin (ATG), total body irradiation, cytomegalovirus (CMV) (urine), and BK polyomavirus (BKV) (urine) were significantly associated with HC. ATG, CMV (urine), and BKV (urine) were independent risk factors for HC based on the multivariate analysis. The Kaplan-Meier survival analysis showed no significant difference between the HC and non-HC groups (<i>P</i> = .14). The 1- and 2-year survival rates in the HC group were 78.4% and 69.6%, respectively, and the corresponding rates in the non-HC group were 84.4% and 80.7%, respectively. ROC analysis indicated that a urine BKV load of 1 × 10<sup>7</sup> copies/mL was able to stratify the risk of HC. In conclusion, when the BKV load is >1 × 10<sup>7</sup>, we need to be aware of the potential for the development of HC.</p>\",\"PeriodicalId\":67343,\"journal\":{\"name\":\"血液科学(英文)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/7e/bls-4-83.PMC9362868.pdf\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"血液科学(英文)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/BS9.0000000000000110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/4/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"血液科学(英文)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/BS9.0000000000000110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 3

摘要

出血性膀胱炎(HC)是异体造血干细胞移植(HSCT)的常见并发症。发病率约为7% ~ 68%,有的患者不得不长期尿频、尿急、尿痛,带来极大的痛苦。本研究旨在分析HC的危险因素及其对患者生存的影响。我们收集了2016年8月至2020年8月在我院接受造血干细胞移植的859例患者的医疗记录。采用基于性别、年龄和诊断的1:1比例的倾向评分对患有和未患有HC的患者进行匹配,并使用逻辑回归分析来确定与HC相关的因素。我们使用Kaplan-Meier曲线分析HC组和非HC组患者的生存率。采用受试者工作特征曲线(receiver operating characteristic curve, ROC)分析BK病毒载量与HC发生的关系。倾向评分匹配后,HC组和非HC组各有131例患者。在HC组中,89例(67.9%)为轻度HC (II期),43例(32.1%)为重度HC (III-IV期)。干细胞移植与HC发育之间的中位间隔为31(3-244)天。单因素分析表明,供者年龄、造血干细胞来源、HLA、急性移植物抗宿主病、布苏丹、抗胸腺细胞球蛋白(ATG)、全身照射、巨细胞病毒(CMV)(尿)和BK多瘤病毒(BKV)(尿)与HC显著相关。多因素分析显示,ATG、CMV(尿)和BKV(尿)是HC的独立危险因素。Kaplan-Meier生存分析显示HC组与非HC组之间无显著差异(P = .14)。HC组1年和2年生存率分别为78.4%和69.6%,非HC组1年和2年生存率分别为84.4%和80.7%。ROC分析表明,1 × 107拷贝/mL的尿BKV负荷能够对HC的风险进行分层。综上所述,当BKV负荷>1 × 107时,需注意HC的发展潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT). The incidence is about 7% to 68%, and some patients have to suffer a long period of frequent, urgent, and painful urination, which brings great pain. This study aimed to analyze risk factors of HC and its effect on patient survival. We collected the medical records of 859 patients who underwent HSCT at our hospital between August 2016 and August 2020. Patients with and without HC were matched using propensity score matching at a 1:1 ratio based on sex, age, and diagnosis, and logistic regression analyses were used to identify factors associated with HC. We used Kaplan-Meier curves to analyze the survival rates of patients in the HC and non-HC groups. We also analyzed the relationship between BK viral load and the occurrence of HC using receiver operating characteristic curve (ROC) analysis. After propensity score matching, there were 131 patients each in the HC and non-HC groups. In the HC group, 89 patients (67.9%) had mild HC (stage II°) and 43 (32.1%) had severe HC (stage III-IV). The median interval between stem cell transplantation and HC development was 31 (3-244) days. Univariate analysis indicated that donor age, hematopoietic stem cell source, HLA, acute graft-versus-host disease, busulfan, anti-thymocyte globulin (ATG), total body irradiation, cytomegalovirus (CMV) (urine), and BK polyomavirus (BKV) (urine) were significantly associated with HC. ATG, CMV (urine), and BKV (urine) were independent risk factors for HC based on the multivariate analysis. The Kaplan-Meier survival analysis showed no significant difference between the HC and non-HC groups (P = .14). The 1- and 2-year survival rates in the HC group were 78.4% and 69.6%, respectively, and the corresponding rates in the non-HC group were 84.4% and 80.7%, respectively. ROC analysis indicated that a urine BKV load of 1 × 107 copies/mL was able to stratify the risk of HC. In conclusion, when the BKV load is >1 × 107, we need to be aware of the potential for the development of HC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
审稿时长
10 weeks
期刊最新文献
Dynamic frailty-tailored therapy (DynaFiT): A proof-of-concept study in elderly patients with newly diagnosed multiple myeloma. Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (KMT2A) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantation. Dual role of BCL11B in T-cell malignancies. Epigenetic modifications in hematopoietic ecosystem: a key tuner from homeostasis to acute myeloid leukemia. Mitochondrial genetic variations in leukemia: a comprehensive overview.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1